ETF Components for XBI - SPDR S&P Biotech ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
SRPT C -0.71 3.31
UTHR B -1.90 3.00
ALNY A 0.43 2.91
GILD C -2.65 2.89
EXAS F 0.05 2.86
AMGN B -0.45 2.84
REGN B -1.97 2.79
BMRN D -1.51 2.77
ABBV C -1.28 2.75
VRTX B -0.74 2.67
NTRA B 0.85 2.67
BIIB C -1.84 2.62
INCY C -2.30 2.55
NBIX C 0.54 2.39
MRNA D -0.96 2.37
VKTX D -2.08 2.32
CYTK D -0.80 1.98
CRSP F 1.48 1.51
MDGL C 0.00 1.47
BPMC B -1.21 1.44
APLS F 1.23 1.43
IONS B 1.02 1.18
EXEL C -0.86 1.14
INSM C -3.88 1.13
KRYS C -0.03 1.11
ALKS D 0.17 1.04
PCVX B 0.26 1.04
RVMD D -1.23 1.04
CERE D -2.26 1.04
HALO B 1.38 1.00
BBIO D 0.36 0.94
TGTX B 2.62 0.87
SWTX D 0.03 0.83
IOVA F -4.40 0.80
RARE F -1.83 0.75
NUVL C -1.30 0.74
DYN C -1.62 0.72
NTLA F 3.61 0.70
TWST C 1.44 0.70
ACAD D -1.58 0.69
CRNX D -2.94 0.69
ACLX B 2.76 0.67
FOLD F -0.41 0.65
RNA C -4.10 0.64
GERN C 4.56 0.63
CLDX D -2.97 0.63
IDYA F -1.28 0.61
BEAM D 4.03 0.60
VERA D -0.11 0.60
ARDX F 0.76 0.57
ARWR C -0.59 0.56
IMVT F -1.21 0.54
SNDX D -2.81 0.52
RXRX F 2.65 0.51
PTCT D 2.01 0.51
NVAX C -3.24 0.50
DVAX F -0.54 0.50
AGIO C -0.07 0.49
DNLI C -2.02 0.49
JANX D -2.04 0.45
VCEL D -0.36 0.44
ADMA B -1.67 0.44
BCRX B -2.14 0.42
RYTM C -3.61 0.42
AKRO D -2.01 0.41
CPRX D -3.10 0.41
NRIX C 2.54 0.41
KYMR D -0.20 0.40
KURA D -2.53 0.38
KROS F -1.49 0.38
RCKT F 1.26 0.37
VCYT C 0.99 0.36
IRWD F -1.77 0.35
PTGX B -0.26 0.35
ARQT B 3.23 0.35
MORF C 1.76 0.35
MYGN B 0.77 0.34
MIRM B 0.59 0.33
FDMT D 1.31 0.29
DAWN F 0.30 0.29
ARCT F 2.09 0.28
PRTA F -1.57 0.28
MNKD C 0.00 0.27
XNCR F 1.92 0.27
VRDN F 0.74 0.26
SANA F -2.43 0.26
CGEM D 2.88 0.25
CGON F -1.56 0.23
COGT C 1.46 0.22
TVTX C -1.85 0.22
RCUS F -1.98 0.21
SAGE F -1.85 0.20
ALT F -2.08 0.20
IMNM F 3.59 0.20
SMMT C -8.62 0.19
CDMO D 14.93 0.19
VIR F -1.02 0.19
ANAB B 4.01 0.18
RLAY F -3.09 0.18
CDNA B -0.07 0.18
RGNX F 0.65 0.17
KNSA C 3.52 0.16
OLMA D 2.50 0.16
OCGN C 1.86 0.15
STOK D -1.25 0.15
EDIT F 2.64 0.15
IRON C 6.75 0.15
SRRK F 1.83 0.15
ETNB F -1.58 0.15
ALLO F -3.70 0.14
CCCC F 0.66 0.13
AVXL C -0.24 0.13
HRTX C 1.09 0.13
MDXG D 0.59 0.13
FATE F -1.86 0.12
SPRY C 4.97 0.11
VERV F 2.80 0.11
CABA F 2.17 0.11
ORIC F 0.00 0.11
VYGR F 1.84 0.10
ZNTL F -2.52 0.10
SVRA D 0.70 0.08
HUMA D 10.96 0.08
ITOS D 2.35 0.08
ALEC F 1.61 0.06

Recent News for SPDR S&P Biotech ETF & its Holdings

Date Stock Title
Jul 3 CYTK Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Jul 3 INSM Insmed sees brensocatib NDA for bronchiectasis in Q4
Jul 3 ABBV AbbVie Q2 IPR&D expenses to lower EPS by $0.52
Jul 3 AMGN S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 VKTX S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 MRNA GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines
Jul 3 BIIB Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
Jul 3 INSM More endpoints met in Insmed’s Phase III brensocatib trial
Jul 3 BIIB Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Jul 3 MRNA GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
Jul 3 INSM Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
Jul 3 SRPT 1 Soaring Growth Stock to Buy and Hold for 10 Years
Jul 3 MRNA Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Jul 3 SRPT Best Momentum Stocks to Buy for July 3rd
Jul 3 ABBV Company News for Jul 3, 2024
Jul 3 AMGN Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
Jul 3 INSM Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 NTRA Natera (NTRA) Soared After a 43% Increase In Revenue
Jul 3 KURA Estimating The Intrinsic Value Of Kura Oncology, Inc. (NASDAQ:KURA)
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Index Fund Stock Market Index Biotechnology S&P Total Market Index ( Biotechnology Segment
Back to the Main XBI Page...